Samsung Biologics announced on the 14th that it has signed a contract manufacturing organization (CMO) agreement worth USD 1.41 billion (approximately KRW 2.74 trillion) with a Europe-based pharmaceutical company.

This is the largest contract in Samsung Biologics' history. It represents 40% of the total order value of KRW 5.4035 trillion last year. The contract will run through December 31, 2030. The customer and product names were not disclosed due to confidentiality.

With the contract, Samsung Biologics has broken its record for the largest order. The record renewal comes just 3 months after the company signed a contract worth KRW 1.7028 trillion with an Asian pharmaceutical company in